e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Pathophysiology of pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension
N. Nickel, T. Kempf, H. Golpon, K. Wollert, M. Wilkins, S. Gibbs, M. Hoeper (Hannover, Lower Saxony, Germany; London, United Kingdom)
Source:
Annual Congress 2008 - Pathophysiology of pulmonary hypertension
Session:
Pathophysiology of pulmonary hypertension
Session type:
E-Communication Session
Number:
291
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Nickel, T. Kempf, H. Golpon, K. Wollert, M. Wilkins, S. Gibbs, M. Hoeper (Hannover, Lower Saxony, Germany; London, United Kingdom). Growth-differentiation factor-15 as a prognostic indicator in idiopathic pulmonary arterial hypertension. Eur Respir J 2008; 32: Suppl. 52, 291
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Towards prognostic biomarkers in pulmonary arterial hypertension
Source: Eur Respir J 2012; 39: 799-801
Year: 2012
Analysis of the cardiac index-PvO2 relationship during vasodilatation challenge as a prognostic factor in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Determinants and prognostic value of kidney disease in pulmonary arterial hypertension
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018
RV/TLC ratio as an independent prognostic indicator in idiopathic pulmonary arterial hypertension (IPAH)
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 342s
Year: 2007
The prognostic role of the electrocardiogram in primary pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001
Plasma interleukin-6 adds prognostic information in pulmonary arterial hypertension
Source: Eur Respir J 2014; 43: 912-914
Year: 2014
Echocardiography and pulmonary embolism severity index have independent prognostic roles in pulmonary embolism
Source: Eur Respir J 2013; 42: 681-688
Year: 2013
Prognostic significance of pulmonary arterial pressure in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis
Year: 2010
Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension
Source: Eur Respir J, 53 (4) 1802067; 10.1183/13993003.02067-2018
Year: 2019
Endothelin-1 and endothelin-3 plasma levels in severe idiopathic pulmonary arterial hypertension
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005
Prognostic role of cardiac troponins and simplified pulmonary embolism severity index in patients with normotensive pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism
Year: 2012
Circulating angiopoietins in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Prognostic predictors in younger and older incident idiopathic pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical physiology
Year: 2013
Novel biomarkers in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010
Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
TAPSE as a prognostic factor in hemodinamically stable pulmonary embolism
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011
Novel biomarkers for risk stratification in pulmonary arterial hypertension
Source: ERJ Open Res 2015; 1: 00008-2015
Year: 2015
Hemoptysis in patients with non-Eisenmenger pulmonary arterial hypertension (PAH)– management and prognostic significance
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Clinical and prognostic value of atrial natriutic peptide in patients with idiopathic pulmonary hypertension
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept